Several novel therapies are now available in the UK for controlling diabetes type 2 . Wegovy , Januvia , and Jardiance represent different approaches, with Saxenda and Mounjaro being injectable GLP-1 receptor mimics primarily aimed at fat reduction alongside sugar levels stabilization, while Metf